2365 Kinetics of cytokine regulation in human NK92 lymphoma cell line
B.R. BROWN, and Z.B. KURAGO, University of Iowa, Iowa City, USA

Natural killer (NK) cells mediate innate immune responses against infections and tumor metastasis. Human NK cell lymphoma NK92, an interleukin-2 (IL-2)-dependent cell line, is one of few cell lines with phenotype and functions similar to normal peripheral blood NK cells. NK92 may serve as a model for NK cell cytokine regulation studies. IL-2, IL-12 and IL-18 regulate NK cell cytokine production, but the mechanisms are not clear. Objectives: To understand the mechanisms of cytokine regulation in NK cells, using NK92 lymphoma as an in vitro model. Methods: We examined kinetics of TNFa and IFNg mRNA expression in response to several cytokines, including IL-18. NK92 subclones were IL-2-starved for 13 hours, then incubated in culture medium alone, or with IL-2, IL-2+IL-12, IL-2+IL-18 or IL-18 only, for 2, 8 or 24hrs. Total RNA was purified using TRI-Reagent (MRC, Cincinatti, OH), and TNFa, GM-CSF, IFNg, and IFNg receptor expression was analyzed by RNase protection assay (RPA) using an RPA kit with 32P-labeled probes synthesized on custom template set (BD Pharmingen, San Diego, CA). Band signal was quantitated by phosphoimaging. Results: Consistent with previous studies, IL-2 alone, or combined with IL-12 or IL-18, up-regulated TNFa and IFNg mRNA expression by 2hrs (earliest measured). IL-2+IL-12 was the strongest stimulus. TNFa mRNA declined more sharply, than did IFNg. However, IL-18 alone had little effect on TNF a, and little to no effect on IFN g mRNA expression. These results differ from those reported by U. Kalina, et al. (J. Immunol. 2000, 165:1307), which could be explained by different experimental conditions. Conclusion: IL-18 alone may not be sufficient to stimulate NK92 IFNg production. This may be physiologically relevant, since IL-18 is expressed in various tissues. IFNg is a potent proinflammatory cytokine that requires tight regulation to prevent unnecessary damage. Supported by NIH/NIDCR P30 DE10126 and by UI Dental Research Award.

Seq #213 - Pathological Mechanisms - Mucosal Diseases, Odontogenic Cysts and Tumours
11:00 AM-12:15 PM, Friday, 8 March 2002 San Diego Convention Center Exhibit Hall C

Back to the Oral Medicine & Pathology Program
Back to the IADR/AADR/CADR 80th General Session (March 6-9, 2002)

Top Level Search